Adagio Therapeutics, Inc. held its Annual Meeting of Stockholders on June 22, 2022, elected Tamsin Berry, Marc Elia and Clive Meanwell as Class I directors, each to serve for a three-year term expiring at the 2025 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | +6.36% | +13.06% | -36.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.29% | 299M | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- IVVD Stock
- News Invivyd, Inc.
- Adagio Therapeutics, Inc. Elects Class I Directors